Aplastic anemia induced by cyclohexylchloroethylnitrousurea

A. Elis, M. Lishner*, H. Savin, M. Ravid

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We report a patient who developed aplastic anemia after three courses of cyclohexylchloroethylnitrousurea (CCNU), procarbazine and oncovine administered after craniotomy and irradiation for brain astrocytoma. To the best of our knowledge, aplastic anemia following CCNU has not been reported previously. The unique course of the disease and implications of this complication are discussed.

Original languageEnglish
Pages (from-to)105-107
Number of pages3
JournalAnti-Cancer Drugs
Issue number1
StatePublished - 1994


  • aplastic anemia
  • cyclohexylchloroethylnitrousurea


Dive into the research topics of 'Aplastic anemia induced by cyclohexylchloroethylnitrousurea'. Together they form a unique fingerprint.

Cite this